Pzena Investment Management LLC Decreases Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Pzena Investment Management LLC reduced its position in Henry Schein, Inc. (NASDAQ:HSIC) by 0.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 983,313 shares of the company’s stock after selling 3,154 shares during the period. Pzena Investment Management LLC’s holdings in Henry Schein were worth $68,045,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC increased its stake in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares in the last quarter. CIBC Asset Management Inc increased its stake in shares of Henry Schein by 1.0% in the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after purchasing an additional 169 shares in the last quarter. Studio Investment Management LLC increased its stake in shares of Henry Schein by 3.8% in the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock worth $341,000 after purchasing an additional 172 shares in the last quarter. Metis Global Partners LLC increased its stake in shares of Henry Schein by 4.7% in the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock worth $291,000 after purchasing an additional 187 shares in the last quarter. Finally, Central Pacific Bank Trust Division increased its stake in Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock worth $706,000 after buying an additional 200 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Stock Up 1.2 %

HSIC opened at $75.45 on Tuesday. The firm has a 50-day simple moving average of $74.57 and a two-hundred day simple moving average of $72.59. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a market capitalization of $9.37 billion, a PE ratio of 31.05, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period last year, the company earned $0.66 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. Analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

HSIC has been the subject of a number of analyst reports. Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Barrington Research reiterated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.